Nanoform Finland Oyj (HEL:NANOFH)
Finland · Delayed Price · Currency is EUR 0.8900
-0.0280 (-3.05%)
May 18, 2026, 6:24 PM EET
Nanoform Finland Oyj Company Description
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States.
The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients.
The company was founded in 2008 and is headquartered in Helsinki, Finland.
Nanoform Finland Oyj
| Country | Finland |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 171 |
| CEO | Edward Haeggstrom |
Contact Details
Address: Cultivator II Helsinki Finland | |
| Phone | 358 2937 00150 |
Stock Details
| Ticker Symbol | NANOFH |
| Exchange | Nasdaq Helsinki |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FI4000330972 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Prof. Edward Olof Haeggstrom | Co-Founder and Chief Executive Officer |
| Albert Alexander Haeggstrom | Chief Financial Officer and Director |
| Henri von Haartman | Director of Investor Relations |
| Peter Hanninen | General Counsel and Chief Development Officer |
| Dr. David Rowe | Head of Manufacturing |
| Christian Jones | Chief Commercial Officer |
| Antonio Da Silva | Chief of Business Operations |
| Johanna Kause | Chief Quality Officer |
| Dr. Jamie Unwin | Vice President of Strategic Insight |